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Abstract. During Xenopus laevis gastrulation, the basic 
body plan of the embryo is generated by movement of 
the marginal zone cells of the blastula into the blasto- 
coel cavity. This morphogenetic process involves cell 
adhesion to the extracellular matrix protein fibronectin 
(FN). Regions of FN required for the attachment and 
migration of involuting marginal zone (IMZ) cells were 
analyzed in vitro using FN fusion protein substrates. 
IMZ cell attachment to FN is mediated by the Arg-Gly- 
Asp (RGD) sequence located in the type III-10 repeat 
and by the Pro-Pro-Arg-Arg-Ala-Arg (PPRRAR) se- 
quence in the type III-13 repeat of the Hep II domain. 
IMZ cells spread and migrate persistently on fusion 
proteins containing both the RGD and synergy site se- 
quence Pro-Pro-Ser-Arg-Asn (PPSRN) located in the 
type III-9 repeat. Cell recognition of the synergy site is 
positionally regulated in the early embryo. During gas- 
trulation, IMZ cells will spread and migrate on FN 
whereas presumptive pre-involuting mesoderm, vegetal 
pole endoderm, and animal cap ectoderm will not. 
However, animal cap ectoderm cells acquire the ability 
to spread and migrate on the RGD/synergy region 
when treated with the mesoderm inducing factor ac- 
tivin-A. These data suggest that mesoderm induction 
activates the position-specific recognition of the syn- 
ergy site of FN in vivo. Moreover, we demonstrate the 
functional importance of this site using a monoclonal 
antibody that blocks synergy region--dependent cell 
spreading and migration on FN. Normal IMZ move- 
ment is perturbed when this antibody is injected into 
the blastocoel cavity indicating that IMZ cell interac- 
tion with the synergy region is required for normal gas- 
trulation. 
F 
IBRONECTIN (FN) 1 is a well characterized  adhesive 
glycoprotein  of  the  extracellular  matrix  (ECM) 
that is implicated in several developmental events 
including  gastrulation, neural crest cell migration, somito- 
genesis, and heart formation (for reviews see Hynes, 1990; 
DeSimone, 1994). FNs are dimers composed of identical 
or near identical subunits joined at their COOH-terminal 
ends by a pair of disulfide bonds. Each subunit consists of 
a series of distinct functional domains that participate in 
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teoglycan; IMZ, involuting marginal zone; MBS, modified Barth's saline; 
MSS, modified Stearn's solution; pFN, plasma fibronectin; Xbra, Xenopus 
brachyury. 
matrix formation, cell binding,  and binding to heparin, col- 
lagen,  and  fibrin  (Sekiguchi  and  Hakomori,  1980; Ya- 
mada, 1990; see also Fig. 1). Multiple forms of FN are gen- 
erated  by  alternative  splicing  of  a  common  transcript 
(Schwarzbauer, 1991; Yamada, 1991). 
Cell adhesion to FN is complex and involves multiple 
cell  interactive sites on the molecule. The tripeptide  se- 
quence Arg-Gly-Asp (RGD), located in the type 111-10 re- 
peat of FN, is essential for the binding of many cell types 
(Pierschbacher  and  Ruoslahti,  1984). An additional  site 
that acts cooperatively with the RGD site to support cell 
adhesion  is  located in  the  type 111-9 repeat  and  corre- 
sponds  to the  sequence Pro-His-Ser-Arg-Asn  (PHSRN) 
(Bowditch  et  al.,  1994; Aota  et  al.,  1994). This  site  is 
termed the "synergy" site. Other cell-binding sites are lo- 
cated in the alternatively spliced V-region of the molecule 
(Humphries et al., 1987; Guan and Hynes, 1990). V-region 
cell-binding sites include the Glu-Ile-Leu-Asp-Val (EILDV) 
(Garcia-Pardo et al., 1990; Komoriya et al., 1991; Wayner 
and Kovach, 1992) and Arg-Glu-Asp-Val (REDV) (Hum- 
phries et al., 1987; Mould et al., 1991) sequences. Some cell 
types are also reported to bind to the COOH-terminal he- 
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1988; Haugen et al.,  1990; Drake et al.,  1992) located in 
type III repeats 13 to 14 (Skorstengaard et al., 1986; McCar- 
thy et al., 1988). 
Cells bind to FNs and other ECM proteins using inte- 
grin receptors (for review see Hynes, 1992). The integrins 
are  a  family of heterodimeric transmembrane  glycopro- 
teins, composed of distinct tx and 13 subunits that interact 
with both the ECM and the cytoskeleton. Different inte- 
grins recognize distinct regions of FN. For example, cq131 
binds to the EILDV site (Garcia-Pardo et al.,  1990; Ko- 
moriya et al., 1991; Wayner and Kovach, 1992) while a5131 
binds to the RGD sequence (Pytela et al., 1985) in cooper- 
ation with the synergy site (Aota et al., 1994; Danen et al., 
1995). 'Several other integrins are also reported to bind FN 
(Hynes, 1992).  Nonintegrin receptors for FN include cell 
surface proteoglycans, some of which bind the HepII site 
(Saunders and Bernfield, 1988; Ruoslahti, 1989; Wight et 
al.,  1992).  These receptors appear to be important in the 
formation of focal contacts and in cell motility (Woods et 
al., 1986). Thus, a cell may modulate its adhesion to FN by 
regulating  the  types  of  integrins  and  cell-surface  pro- 
teoglycans it expresses. 
In Xenopus, cDNAs encoding FN and several integrin 
subunits have been cloned and characterized (DeSimone 
and Hynes, 1988; DeSimone et al.,  1992; Whittaker and 
DeSimone, 1993; Ransom et al., 1993; Joos et al., 1995; Lal- 
lier et al., 1996). FN is secreted by cells from all regions of 
the early embryo and becomes localized to the ECM that 
forms along the blastocoel roof (Lee et al.,  1984). During 
gastrulation involuted marginal  zone (IMZ)  cells, which 
include both mesoderm and endoderm, come in contact 
with this FN  matrix.  In  Xenopus and  urodele embryos, 
mesoderm migration is inhibited following the injection of 
anti-FN  antibodies  into  the  blastocoel  (Boucaut  et  al., 
1984a; Howard et al., 1992; Ramos et al., 1996). Addition- 
ally, dispersed Xenopus IMZ cells will spread and migrate 
on the inner surface of excised blastocoel roofs and on FN- 
coated petri dishes (Nakatsuji and Johnson, 1983; Winkl- 
bauer, 1988, 1990).  Although all cells of the early embryo 
are  able  to  attach  to  the  RGD-containing  central-cell- 
binding domain of FN, only IMZ cells spread and migrate 
on this region in vitro (Ramos et al., 1996). 
Gastrulation  is  the morphogenetic process that  estab- 
lishes the three primary germ layers in their relative posi- 
tions in the embryo. Mesoderm induction plays an essen- 
tial role by initiating the  cellular movements associated 
with this event (for review see Dawid  and Taira, 1994). 
Smith et al.  (1988) have developed an in vitro mesoderm 
induction assay that mimics normal inductive signals that 
arise from the vegetal pole of the embryo. In this system, 
animal pole tissue normally fated to become ectoderm is 
induced to form mesoderm and undergo gastrulation-like 
movements when exposed to activin-A, a member of the 
TGF-13 family of growth factors. Animal cap cells, which 
normally only attach to FN, gain the ability to spread and 
migrate on this ECM protein following exposure to activin 
(Smith et al., 1990; Howard and Smith, 1993). 
In this study we address the contributions of individual 
FN cell-binding sites to the adhesion, spreading, and mi- 
gration of IMZ and activin-induced animal cap cells. We 
show that three cell-interactive regions of FN are used by 
these  cells:  the  RGD  site,  the  synergy region,  and  the 
HeplI domain. The RGD site and the HeplI region both 
support the  attachment of all cells of the  early embryo, 
however, IMZ cell spreading and migration require a syn- 
ergy site in combination with the RGD site. Moreover, an 
antibody that inhibits synergy region-dependent cell mi- 
gration on FN, but not interaction with the RGD site, per- 
turbs gastrulation. These data demonstrate that IMZ cell 
recognition of the synergy region is positionally specified 
in vivo in response to mesoderm inducing signals. 
Materials and Methods 
Xenopus Embryos 
Adult X. laevis wild-type and albino animals were purchased from Xeno- 
pus 1 (Ann Arbor, MI). Eggs and embryos were obtained as described in 
Newport and Kirschner (1982).  Embryos were cultured in 0.1×  Modified 
Barth's Saline (MBS; Gurdon, 1977) and staged according to Nieuwkoop 
and Faber (1994). 
PCR Amplification of 9.11, EIIIA, EIIIB, 
and V-regions 
Forward and reverse oligodeoxynucleotide primers containing engineered 
restriction sites were produced using a PCR-Mate oligodeoxynucleotide 
synthesizer (Applied Biosystems, Foster City, CA). Primer sequences are 
listed in Table I. EIIIA, EIIIB, and V-region amplifications were carried 
out in separate 100-txl reactions containing 1 p~g of forward and reverse 
primers and 20 ng of template cDNA (Xenopus FN clone pN4L; DeSi- 
mone et al., 1992). Target regions were amplified in 30 cycles (94°C, 1 min; 
50°C, 2 min; 72°C, 3 min) using Taq DNA polymerase (Perkin-Elmer, Fos- 
ter City, CA). Similarly, the type III-9 to type III-11 segment of FN was 
amplified using 1 ~g of each primer and 100 ng of template cDNA clone 
pF7 (DeSimone et al., 1992) in 20 cycles (94°C, 1 min; 48°C, 1 min; 72°C, 
3  min)  using Vent polymerase (New  England-Biolabs, Beverly,  MA). 
Each amplified DNA was gel purified and sequenced using the dideoxy 
chain-termination method (Sanger et al., 1977) after subcloning into suit- 
able  pGEX  expression vectors  (Smith  and  Johnson,  1988; Guan  and 
Dixon, 1991) as described below. 
Construction of  Fibronectin Fusion Proteins 
To express specific regions of FIN as fusion proteins, PCR amplified cDNAs 
were  digested  with  appropriate  restriction  enzymes  and  ligated  into 
pGEX-2T (GST-A and GST-B) or pGEX-KG (GST-V). Additional FN 
fusion proteins were constructed by subcloning DNA fragments from pre- 
viously isolated  Xenopus  FN clones (DeSimone et  al.,  1992)  into the 
pGEX-2T (GST-4.13A0, GST-10, GST-9.10 and GST-1.9) or pGEX-3X 
(GST-12.12  and GST-12.15)  plasmids. The recombinant plasmids were 
transformed into E. coli HB101  and fusion proteins induced following the 
addition of IPTG as described in Smith and Johnson (1988). Fusion pro- 
teins were affinity purified on glutathione-agarose beads and eluted in 10 
mM free-reduced glutathione (Sigma Chemical Co., St. Louis, MO). The 
preparations  were  dialyzed  against  PBS  and  analyzed  by  10%  SDS- 
PAGE. 
Construction of GST-9.11e, GST-9.11a, 
and GST-12.15  VO 
Site-directed mutagenesis of pGEX-9.11 was performed by inverse PCR 
(Hemsley et al., 1989). Similarly, the V-region was deleted from pGEX- 
12.15 using inverse PCR deletion mutagenesis. In summary, forward and 
reverse primers (Table  I)  were designed to abut  one another (pGEX- 
9.11e, pGEX-9.11a) or the region to be deleted (pGEX-12.15V0) so that 
the amplified product would contain both vector and altered insert se- 
quences. The forward primer for the GST-9.11e construct contains a sin- 
gle base change resulting in a glutamic acid to aspartic acid substitution at 
position 1617 of XFN while the GST-9.11a primer contains a single base 
change resulting in an arginine to alanine substitution at position 1533. In 
100-1xl reactions, 1 Ixg of each primer (JR3 and JR4, JR5 and JR6, or JR1 
and JR2) was mixed with 200 ng of template DNA (pGEX-9.11 or pGEX- 
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Region amplified  Primer sequence 
V-region forward 
V-region reverse 
EIIIB forward 
EIIIB reverse 
EIIIA forward 
EIIIA reverse 
111-14 (JR1) 
III- 15 (JR2) 
III- 10 (JR3; RGD>RGE 
III- 10 (JR4) 
11I-9 (JR5; SRN>SAN) 
III-9 (JR6) 
III- 10 (JR8) 
5'-ATGCTCGAGGACGAACTCCCCCGCCTGGGTTACA-3' 
5 '-GCGAAGCTTATAAGCCATGAGGGTAAGGAC-3' 
5'-CGGAATTCATGAGATACCCCAACTGA-3' 
5 '-CGGAATTCCGTATCCTGTATGATT-3  ' 
5 '-CGGAATTCATAACATTGACAATCCCA-3  ' 
5 '-CGGAATTCTGTGCTCTGGATCCCA-3  ' 
5'-TGTTCTCTTACGTCC-3' 
5'-GGGCCACAGCTGAAT-3' 
5 '-AGAGGAGAGAGTCCAGC-3  ' 
5 '-CCCAGTCACTGCATAAAC-3  ' 
5'-CCATCCGCGAACTCTATC-3' 
5 '-AGGTACCCGCTCCTCCTT-3  ' 
5'-CGGTCGACTGTCTTGTGAATAATGGT-3' 
12.15)  and the target region amplified in 25 cycles (94°C, 1 min; 48°C, 2 
min; 72°C, 12 min) using Pfu polymerase (Stratagene, La Jolla, CA). The 
amplification products were blunted with Klenow, treated with T4 polynu- 
cleotide kinase, gel purified, and ligated. Each construct was sequenced to 
verify the success of the mutagenesis. 
Construction of GST-6.15, GST-6.15e, GST-6.15VO, 
and GST-6.15eVO 
The constructs described above were subsequently used along with clones 
pN4 and p4L (DeSimone et al., 1992)  to build a series of fusion protein 
constructs extending from type III-6 to type III-15, and differing in their 
content of the RGD and V-regions (see Fig. 1). Inverse PCR site-directed 
mutagenesis was performed on pN4 as described above for pGEX-9.11e 
to  yield  an  RGE-mutated  form  of pN4  (pN4e).  pGEX-6.15  was  con- 
structed from pN4, p4L,  and pGEX-12.15  using convenient restriction 
sites. Similarly, pGEX-6.15e was constructed from pN4e, p4L, and pGEX- 
12.15;  pGEX-6.15V0  from pN4,  p4L,  and pGEX-12.15V0;  and pGEX- 
6.15eV0 from pN4e, p4L, and pGEX-12.15V0. The final constructs were 
subcloned from Bluescript into pGEX-1. Each construct was partially se- 
quenced to confirm orientation, identity, and continuous reading frame. 
Antibodies 
The GST-9.11 fusion protein was used to immunize BALB/c mice (Hill- 
top) by subcutaneous and interperitoneal injection (100 fxg). Hybridoma 
fusion and cloning were performed using standard methods (Chapman et 
al., 1984)  and culture supernatants screened by ELISA and Western blot 
for immunoreactivity to Xenopus plasma FN (pFN), GST-9.11, or GST. 
Two hybridomas were selected on the basis of immunoreactivity with pFN 
and GST-9.11 (1F7) or GST alone (1C9). A third hybridoma (4H2), which 
also recognizes pFN and GST-9.11, was obtained from a previous fusion 
where intact Xenopus pFN was used as immunogen (Ramos et al., 1996). 
Monoclonal antibodies from all three hybridomas were isotyped as IgG1. 
Ascites fluids were generated by injecting 106 hybridoma cells into IRCF1 
mice, primed 10 d earlier with pristane (Hoogenraad and Wraight, 1986). 
Purified IgG1 was obtained from ascites by recombinant protein G affin- 
ity chromatography (Pharmacia LKB Biotechnology, Piscataway, NJ). FN 
type III-repeat epitope mapping for the 4H2 and 1F7 antibodies was done 
by Western blot using a series of Xenopus FN fusion proteins. 
Preparation of Substrates and Cell Adhesion and 
Migration Assays 
Protocols for substrate preparation, attachment, and spreading assays are 
described in detail in Ramos et al. (1996). Briefly, marked areas of plastic 
petri  dishes  (Falcon:  Becton-Dickinson  Co.,  Lincoln  Park,  NJ)  were 
coated overnight at 4°C with a  50-pA drop of phosphate buffer (pH 7.5) 
containing 0.5 j.LM human plasma FN (HpFN), GST fusion proteins or 5 
p.g/ml  RGD  peptide  (Peptite-2000;  Telios, La Jolla,  CA).  Dishes were 
washed with 0.1  x  MBS followed by a  30-min incubation in Modified 
Stern's Solution (MSS; DeSimone and Johnson, 1991)  containing 0.5% 
BSA. In parallel experiments, the anti-GST mAb 1C9 was used by ELISA 
to confirm that each fusion protein was adsorbed to the plastic surface at 
approximately equimolar amounts. 
A  plug of involuted embryonic cells consisting of presumptive meso- 
derm and endoderm was dissected out of stage 11-11.5 embryos and dis- 
persed in Ca .'+. and Mg++-free 1x MBS (CMF-MBS) for 30 min (see Fig. 
2). Identical methods were used to isolate additional embryonic regions, 
such as those indicated in the diagram in Fig. 8. Approximately 600 dis- 
persed cells per experiment were added to coated substrates by mouth pi- 
pette and incubated for 1 h in MSS (pH 8.3) containing 0.5% BSA, 1 mM 
CaCI2 and 1 mM MgCI2. Acfivin induction assays were performed by dis- 
secting animal caps from stage 8 embryos and dispersing the cells in CMF- 
MBS until control  embryos reached  stage 9.5  (Fig.  2).  Dispersed cells 
were added to coated substrates and incubated for 2 h in MSS as above or 
in MSS containing 20 U/ml of activin A, kindly provided by Dr. Jim Smith 
(MRC, Mill Hill, London, UK). In each experiment three to five marked 
regions were photographed and the plates inverted in buffer for 5 min. 
The same regions were then photographed again. Cells counted as spread 
were attached to the substrate, flattened, and had at least two lamellipodia 
(Fig. 3, A and B). Cells counted as attached were spherical and remained 
bound to the plate during the inversion in buffer (Fig. 3, C and D). Cells 
counted as nonattached were spherical and fell away during inversion. 
Cells were photographed on a Zeiss Axiovert microscope equipped with 
Hoffman optics. Most experiments were repeated at least eight times. 
For  migration  assays, embryonic  cells  were  obtained  as  described 
above and applied to Xenopus pFN or fusion protein coated substrata. 
Cell cultures were monitored on a Zeiss Axiovert using time-lapse video 
microscopy (4-s interval). Tracings of individual cells were made from the 
monitor following video playback. At least 10 cells per substrate per ex- 
periment were followed at 5-min intervals and the rates of migration cal- 
culated. 
Antibody and GAG Blocking Assays and Microinjection 
Blocking antibodies were tested in vitro using fusion protein and pFN sub- 
strates prepared as described above. Substrates were blocked with 0.5% 
BSA in MSS, rinsed, and then incubated with various FN antibodies (1 rag/ 
ml) at 25°C for 1 h. The coated petri dishes were then washed three times 
with MSS before the addition of dispersed IMZ cells. Similar methods 
were used to pretreat substrates with 1 p~g/ml each of heparan sulfate (low 
tool  wt form), dextran sulfate, or chondroitin sulfate (Sigma Chemical 
Co.).  In all cases, cell attachment and spreading were quantified as de- 
scribed above. 
The 4H2 control and 1F7 migration blocking antibodies were used for 
microinjection  at  a  concentration  of 10  mg/ml in  Danilchik's solution 
(Shih and Keller, 1992). Antibodies were centrifuged at 16,000 g for 5 rain 
at 4°C just before injection. Siliconized glass needles (PLI-CS:  Medical 
Systems Corp., Greenvale, NY) were pulled and the tips bevelled using a 
Narishige  PB-7  puller  and  EG-4  grinder  (Narishige  USA,  Greenvale, 
NY), respectively. A  pressure driven injector (PLI-100: Medical Systems 
Corp.) was used to deliver a 30-nl pulse of antibody solution into each of 
the two separate sites of the blastocoel at stage 9.5. All embryos were in- 
jected and cultured in 0.1x MBS and scored for gastrulation defects. Em- 
bryos  were  imaged  using a  Zeiss  STEMI-2000  dissecting  microscope 
equipped with a Kodak DCS420c digital camera. 
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Whole mount in situ hybridizations were performed on albino embryos as 
described  by  Harland  (1991)  using digoxigenin-rUTP-labeled  (Boeh- 
ringer  Mannheim)  transcripts  synthesized  in  vitro  from  a  Xenopus 
brachyury cDNA (Xbra)  obtained from Dr. Jim Smith (Smith et al., 1991). 
Embryos were cleared in 2:1 (vol/vol) benzyl-alcohol/benzyl-benzoate be- 
fore  recording  with  the  DCS420c  camera  on  a  Zeiss Axiophot using 
bright-field optics. 
Results 
Marginal Zone Cell Adhesion Requires Both the RGD 
and Synergy Sites 
We reported  previously the  cloning of cDNAs encoding 
Xenopus fibronectin (XFN; DeSimone et al., 1992). In the 
current  study  we  used  these  cDNAs  to  construct  three 
general groups of FN-GST fusion proteins (Fig. 1) in order 
to identify regions of the molecule involved in embryonic 
cell adhesion and migration. The first group was designed 
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Figure 1. The structure of Xenopus FN (XFN) and related fusion 
proteins. One subunit of the XFN dimer is shown including all 
known splice  variants with specific  functional-binding domains 
indicated above the molecule. Each subunit contains three repeat 
motifs termed types I, II, and III. In Xenopus, alternative splicing 
of a common transcript can result in the complete exclusion or in- 
clusion of the EIIIA and EIIIB exons (black boxes) and the V-region 
(hatched box) (DeSimone et al., 1992). All Xenopus FN fusion 
proteins were produced in the pGEX bacterial expression system 
and contain glutathione-S-transferase (GST) at their NH  2 termini 
(Smith  and Johnson, 1988). The two maltose-binding (MBP) fu- 
sion proteins designated by asterisks  were constructed from rat 
FN  cDNAs  and  were  generously  provided  by  Drs.  Fern  J. 
Barkalow  and  Jean  E.  Schwarzbauer  (see  also Barkalow  and 
Schwarzbauer, 1991). 
to evaluate the importance of the RGD-containing central 
cell-binding domain of FN (Fig.  1, e.g., GST-9.11 series). 
The second group was used to test the contributions of the 
HeplI and V-regions (Fig. 1, e.g., GST-12.15 series).  The 
GST-6.15 series and GST-1.9 were used to confirm results 
obtained with the  smaller fusion proteins  and to test for 
possible  c/s-acting functional complementarity.  Other fu- 
sion  proteins  include  nonadhesive  controls  (Fig.  1,  e.g., 
GST-B,  GST-A,  and  GST  alone).  Fusion  proteins  were 
used as substrates in in vitro adhesion assays with isolated 
Xenopus  involuted  marginal  zone  (IMZ)  or  animal  cap 
cells (Fig. 2). Representative  examples of cell adhesion to 
these fusion proteins are presented in Fig. 3 and discussed 
below. 
Our  initial  experiments  addressed  whether  the  RGD 
site of FN is sufficient to support adhesive and migratory 
behaviors of IMZ cells, as has been suggested in previous 
studies (Boucaut et al., 1984b; Winklbauer, 1990; Smith et 
al., 1990). Several RGD-containing fusion proteins (GST- 
4.13A0, GST-9.11, and GST-9.10) support the attachment 
and spreading of IMZ cells to the same extent  as HpFN 
(Figs.  3  and 4  A).  The  smallest  of these  fusion proteins 
(GST-9.10)  corresponds  to the  type 111-9 to type III-10 
repeat  regions  of FN.  The  RGD  containing type III-10 
repeat alone (GST-10) supports attachment but not spread- 
ing (Fig. 4 A). Therefore, the type 111-9 repeat is also re- 
quired  for the  spreading  of these  cells.  Not surprisingly, 
Stage 8  Stage 10.5 
Embryo Dissection 
Animal Cap  "Mesoderm" 
0  0  0  0 
0  000  0  0  0  0  0  0 
0  0  0 
0  0  0  0  0  0  0  0 
0  0  0 
0  0  0  0 
MSS +/-ActMn  MSS 
Dissociation and 
dispersal In CMF-MBS 
Incubation of slngle 
ceils  on fuslon 
protein  suls~ITata 
Figure 2.  In vitro adhesion assays. Fusion proteins are applied in 
equimolar (0.5 I~M) amounts to marked areas of Petri dishes and 
then blocked with 0.5% BSA. Animal caps or presumptive meso- 
derm (IMZ cells) are dissected and dispersed in CMF-MBS and 
cultured on fusion protein substrata for 2 h. Animal cap cells are 
cultured in the presence or absence of activin-A. Cells are counted 
and the cultures inverted in buffer for 5 min to remove nonadherent 
cells. The cells that remain after inversion are then counted. Mi- 
gratory behavior is recorded by time-lapse video microscopy. 
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Figure 3.  Morphology of embryonic cells on representative cell 
interactive  sites of FN. Cells of the involuted  mesoderm extend 
several lamelliform protrusions becoming polygonal in shape on 
(A) HpFN and (B) GST-9.11. We refer to this  morphology as 
"spread." Involuted mesoderm cells attach but remain round on 
(C) RGD (Peptite) and (D) GST-9.11a, but can extend filopodia 
(arrow in  C). We refer to this morphology as "attached." Bar: 
(D) 100 p~m. 
RGD peptide  (Peptite)  supports cell attachment but not 
cell spreading. The amino acid sequence PHSRN (PPSRN 
in Xenopus)  located in the type III-9 repeat of FN is re- 
ported to be required for the spreading of many cell types 
(Aota et al., 1994;  Bowditch et al., 1994).  IMZ cell adhe- 
sion to a fusion protein in which this sequence is mutated 
to PPSAN  (GST-9.11a) is indistinguishable  from that on 
type III-10 alone  (Fig.  4  A;  GST-10). Thus,  RGD  is the 
minimum sequence required for IMZ attachment, but the 
PPSRN-containing  synergy site  located in  the  type  III-9 
repeat is necessary to support cell spreading. 
The importance of the RGD site is confirmed by the fu- 
sion protein  GST-9.11e, which is identical to fusion pro- 
tein GST-9.11 with the exception of an aspartic acid (D) to 
glutamic acid  (E)  mutation in  the  RGD  site.  GST-9.11e 
does not support attachment or spreading (Fig. 4  A).  In 
experiments where GST-9.11e and peptite were coated to- 
gether, no spreading was noted (data not shown). There- 
fore, the RGD sequence is the primary site of IMZ cell at- 
tachment to the GST-9.11 fusion protein acting in cis with 
a synergy region to support cell spreading. The synergy re- 
gion  alone  is  not  sufficient  to  support  attachment  or 
spreading (GST-9.11e; Fig. 4 A). 
IMZ Cells Attach to the Heparin-binding Region but 
Not the V-Region 
Adhesion to the COOH-terminal half of FN was investi- 
gated by comparing the relative contributions of the HepII 
and V-regions. Fusion proteins GST-12.12 and GST-12.15 
(Fig. 1) contain both the V- and HepII regions, the latter 
of which corresponds to the type III-13 and type III-14 re- 
peats (McCarthy et al.,  1988).  To distinguish the relative 
adhesive activities of the HepII and V-regions the V-region 
alone (GST-V) and a V-region minus version of GST-12.15 
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Figure 4.  IMZ cell attachment and spreading on FN fusion pro- 
teins.  Data are expressed as the percent of cells spread (black 
bars) compared to the percent of cells attached (gray bars). (A) 
IMZ cells attach  to  fusion  proteins containing  the  RGD  site. 
Cells spread only on fusion proteins containing  both the RGD 
and synergy site. (B) IMZ cells attach but do not spread on fusion 
proteins containing HeplI. (C) IMZ cell attachment to the RGD/ 
synergy region is not affected by the HeplI region. At least 500 
cells were counted per substrate per assay. Each assay was re- 
peated eight times (n  =  8). Error bars indicate  standard devia- 
tions. 
(GST-12.15V0)  were  also  tested.  Cells  do  not  attach  to 
GST-V  indicating  that  this  region  is  not  recognized  by 
IMZ cells (Fig. 4 B). Fusion proteins containing the HeplI 
region (GST-12.12, GST-12.15, and GST-12.15V0) support 
comparable levels of IMZ attachment but not spreading; 
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able influence on adhesive activity in these assays (Fig.  4 
B).  Ceils derived from embryos injected with integrin a 4 
transcripts  will  adhere  to  GST-V indicating that  the  re- 
combinant fusion protein has functional activity (Ramos 
et al., 1996). 
To investigate further the specificity of embryonic cell 
attachment to the HepII region fusion protein substrates 
were preincubated with chondroitin sulfate,  dextran sul- 
fate,  or  heparan  sulfate  before  the  application  of IMZ 
cells.  Both heparan sulfate  and  dextran sulfate  interfere 
with IMZ attachment while chondroitin sulfate has no af- 
fect (Fig. 5).  None of the glycosaminoglycans tested had 
any affect on IMZ adhesion to GST-9.11. These data sug- 
gest that IMZ cells may bind to the HeplI region using cell 
surface proteoglycans. We examined the cation dependency 
of cell attachment to the HeplI region by performing ad- 
hesion assays in the presence (Fig. 6, A and C) or absence 
(Fig. 6, B and D) of free calcium. Cells were plated on sub- 
strates containing HpFN, GST-9.11, GST-12.15, and GST- 
12.15V0 alone (Fig.  6, A  and B) or preincubated with free 
heparan sulfate (Fig. 6, C and D). Removal of calcium from 
the  medium has no affect on IMZ attachment to HeplI 
containing fusion proteins (Fig. 6 B; GST-12.15 and GST- 
12.15V0), however, attachment to the RGD/synergy fusion 
protein  (GST-9.11) is inhibited  (Fig.  6 B).  As predicted, 
IMZ cells  attach to intact HpFN under these  conditions 
but  do not spread  (Fig.  6  B).  Preincubation of the  sub- 
strates with free heparan sulfate has no affect on IMZ at- 
tachment to GST-9.11  but  inhibits  attachment to  HeplI 
containing fusion proteins  (Fig.  6  C).  Interestingly, both 
preincubation of the  substrate  with free heparan sulfate 
and removal of cations from the solution are required to 
inhibit completely IMZ attachment to the entire FN mole- 
cule (Fig.  6 D; HpFN). These studies  indicate that IMZ 
cell attachment to HeplI containing fusion proteins is cat- 
ion independent and suggests a nonintegrin-dependent in- 
teraction involving recognition by cell-surface proteogly- 
cans. 
The sequence PPRRAR (PPRRPR in Xenopus) has been 
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Figure 5.  Free glycosaminoglycans  (GAGs) were used to investi- 
gate the specificity of cell adhesion to the HeplI domain of FN. 
Heparan sulfate and dextran sulfate but not chondroitin sulfate 
(substrates pre-incubated with 1 p,g/ml of each GAG) block the 
attachment  of IMZ cells to the HeplI containing fusion protein 
GST-12.15, but  have no affect on the  adhesion  of cells to the 
RGD/synergy  containing  GST-9.11. At  least  500  cells were 
counted  per substrate  per assay. Each assay was repeated  two 
times (n = 2). Error bars indicate standard deviations. 
shown to support the adhesion of some cell lines  to the 
HeplI  region  (Barkalow  and  Schwarzbauer,  1991).  We 
used  a  rat FN fusion protein containing a  Thr  and Met 
substitution  for  two  of  the  arginines  in  this  sequence 
(PPRRAR >  PPTMAR) in order to determine if this site 
is required for IMZ cell attachment to the HeplI region. 
Our data indicate that IMZ cells will not attach to a fusion 
protein containing this substitution (MBP-HVOTM). The 
control fusion protein (MBP-HVO) supports IMZ adhe- 
sion equivalent to that described for the Xenopus FN fu- 
sion proteins that correspond to this region (Figs.  4 B, 5, 
and 6 A). Cells from the endoderm and ectoderm of gas- 
trulae  also  attach  (Fig.  8  E)  but  do not  spread  on  the 
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Figure 6.  Adhesion of involuted marginal zone cells to the HeplI 
region of FN is Ca  ++ independent. IMZ cells attached (gray bars) 
and spread (black bars) are indicated. (A) IMZ cells spread on 
HpFN and GST-9.11, both of which contain the RGD site and 
synergy region, but only attach to GST-12.15 and GST-12.15V0 
which contain the HeplI site. (B) In Ca++-free MBS containing 
10 IxM EDTA, the cells do not attach to GST-9.11 but remain at- 
tached to HpFN, GST-12.i5, and GST-12.15V0, all of which con- 
tain the HeplI site. (C) When the substrates  are pre-incubated 
with heparan sulfate (1 ~g/ml) and washed before performing the 
adhesion assay, the cells no longer attach to the HepII containing 
fusion proteins,  but  adhesion  to RGD/synergy-containing pro- 
teins, GST-9.11 and HpFN, is unaffected. (D) When substrates 
are preincubated in the presence of free heparan sulfate and the 
adhesion assay is performed in the presence of 10 ixM EDTA, no 
cells attach. (E) Attachment  to the HepfI-containing  region of 
rat FN is lost when the cells are plated on a fusion protein con- 
taining  a  PPRRAR  to  PPTMAR  mutation  (Barkalow  and 
Schwarzbauer, 1991). At least 500 cells were counted per sub- 
strate per assay in E. Each assay was repeated three times (n = 3). 
Error bars indicate standard deviations. 
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the RGD site alone, is not specific for IMZ cells. 
IMZ Adhesion to RGD/Synergy Is Unaffected by the 
Presence of the HeplI Region 
It is possible that RGD/synergy, HepII, and V-region ad- 
hesive activities differ when presented in cis. To address 
this question,  fusion proteins spanning all three of these 
regions and differing only in their content of the RGD site 
and  V-region were constructed  (Fig.  1).  When  both the 
HepII and RGD/synergy sites are present in the same fu- 
sion  protein  (GST-6.15,  GST-6.15V0,  and  GST-4.13A0), 
attached cells behave as they would on RGD/synergy alone 
(e.g., GST-9.11; Fig. 4, A and C). Additionally, when GST- 
9.11 is used in combination with equimolar amounts of fu- 
sion proteins containing the HepII region, the cells behave 
as they do on the RGD/synergy proteins alone (data not 
shown). Thus, with respect to IMZ attachment and spread- 
ing, there is no evidence for cis or trans acting complemen- 
tation among these regions in our assays. 
When  HepII and  the  synergy site are present without 
the  RGD  site  (GST-6.15e  and  GST-6.15eV0),  however, 
some cell spreading can be detected (Fig. 4 C). When IMZ 
cells are cultured on mixed fusion protein substrates con- 
taining equimolar concentrations of HepII (GST-12.15V0) 
and the synergy site (GST-9.11e) they do not spread (data 
not  shown).  Therefore, these  data suggest that some cis 
complementarity of the synergy region-containing central 
cell-binding domain with the Hep II region is possible in 
the absence of an intact RGD site. In all cases, we have 
been unable to detect any adhesive role for the V-region 
in these assays consistent with a lack of integrin oq expres- 
sion by these cells (Ramos et al., 1996). 
We also investigated whether additional regions of FN 
support IMZ attachment in vitro. GST-1.9 corresponds to 
the NH2-terminal half of FN and contains the low affinity 
heparin-binding site (HepI) and a portion of the synergy 
region. GST-A and GST-B contain only the alternatively 
spliced  EIIIA and  EIIIB domains,  respectively. Neither 
attachment nor spreading of cells was supported by any of 
these fusion proteins even at plating concentrations up to 
10 mM (Fig. 4 B and data not shown). 
Activin Induced Animal Cap Cells Recognize the 
RGD/Synergy Site 
Treatment of Xenopus blastula stage animal cap cells with 
20  U/ml  activin-A  results  in  the  attachment,  spreading, 
and migration of these cells on FN (Smith et al., 1990). Un- 
treated cells attach but remain rounded.  We were inter- 
ested  in  determining  whether  the  mechanism  by which 
spreading and migratory behaviors of activin induced ani- 
mal cap cells is regulated involves the recognition of multi- 
ple cell-interactive sites on FN. Consequently, animal caps 
were dissected from stage 8-9 embryos and the cells dis- 
persed in CMF-MBS (Fig. 2). Dispersed cells were applied 
to fusion protein coated substrata in the presence or ab- 
sence of 20 U/ml activin-A (Fig. 7). Greater than 90% of 
noninduced  cells  attach  to  the  RGD  sequence  and  the 
HeplI region, alone or in combination (Fig. 7 A), similar 
to that observed for IMZ cells (Fig. 4). Unlike IMZ, how- 
ever, these cells do not spread on RGD/synergy-contain- 
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Figure 7.  Only activin-A-induced animal cap cells recognize the 
synergy region of FN. Solid bars represent a percentage of cells 
attached;  gray bars represent a percentage of cells spread.  (A) 
Noninduced  dissociated animal cap cells attach but do not spread 
on the RGD/synergy region (GST-4.13A0, GST-9.11, and GST- 
9.10) and on Hep II (GST-12.12, GST-12.15, and GST-12.15V0). 
(B) Activin-induced  animal cap cells attach and spread on FN fu- 
sion proteins containing  an intact  RGD and synergy site (GST- 
4.13, GST-9.10, and GST-9.11), but do not spread on either site 
alone (GST-10,  GST-9.11e,  GST-9.11a,  and PepTite). Activin- 
induced  animal cap cells (B), like IMZ cells, do not spread on 
Hep II (GST-12.15 and GST-12.15V0). Noninduced  cells (A) do 
not spread on any of the substrata.  Neither induced  or nonin- 
duced cells are able to attach to the synergy (GST-9.11e) or V re- 
gions (GST-V) alone.  At least 500 cells were counted per sub- 
strate per assay. Each assay was repeated eight times  (n  =  8). 
Error bars indicate standard deviations. 
ing fusion proteins. Animal cap cells do not attach to the 
RGE-containing  fusion  protein  (GST-9.11e)  or  to  the 
V-region alone (GST-V, Fig. 7 A). 
Animal  cap cells treated with  activin-A also attach to 
both the RGD and the HeplI region, however, they spread 
only on RGD/synergy site containing fusion proteins (Fig. 
7 B) in a  manner indistinguishable  from that of endoge- 
nously induced  IMZ. The cells do not  spread on fusion 
proteins in which the synergy site has been mutated (GST- 
9.11a) or is absent (GST-10). Therefore, activin induction 
leads to animal cap cell "recognition" of the synergy site. 
Moreover, this change in animal cap cell adhesive behav- 
ior begins within 30--60 min after application of activin and 
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1996). 
Synergy Region-dependent  Adhesive Behavior Is 
Temporally and Spatially Regulated in the Embryo 
The fusion protein studies indicate that the adhesive be- 
haviors of activin-induced animal cap and explanted IMZ 
cells on specific FN cell-interactive sites are indistinguish- 
able in vitro. ~Phis suggests that normal mesoderm induc- 
tion leads to the position-specific activation of RGD/syn- 
ergy region recognition in vivo. To test this hypothesis, 
regions of stage 8 and stage 11 embryos were dissected be- 
fore and after involution as shown in Fig. 8, and applied to 
fusion protein-coated substrates. 
Cells obtained from each of several different regions of 
blastula stage embryos attach but are unable to spread on 
intact human pFN or on any of the Xenopus FN fusion 
protein substrates  (Fig.  8,  B-E).  These cells appear the 
same on each fusion protein with the synergy region mu- 
tant (GST-9.11a) supporting slightly less attachment than 
the others (Fig. 8 D). As gastrulation begins, cells of the 
dorsal lip and IMZ move into the embryo. Involuting cells 
gain the ability to attach and spread on the RGD/synergy 
fusion  protein  (Fig.  8  C;  GST-9.10),  but  are  unable  to 
spread on a fusion protein containing the synergy region 
mutation (Fig.  8  D;  GST-9.11a). Cell attachment to the 
HeplI site remains unchanged before and after involution 
(Fig.  8  E;  GST-12.15V0).  These data  suggest  that  IMZ 
cells come in contact with endogenous signals which, like 
activin-A, induce them to recognize the synergy site. 
The RGD/Synergy Site Is Required  for Embryonic Cell 
Migration on FN 
Fusion proteins containing the RGD/synergy region (GST- 
4.13A0  and  GST-9.11)  support  migration  of  both  ex- 
planted IMZ and activin-induced animal cap cells at a rate 
similar to that on HpFN (~180 t~m per hour; Fig. 9). In 
vivo, the mesoderm advances along the blastocoel roof at 
a comparable rate of 120 ~m per hour (Keller and Winkl- 
bauer,  1992).  Time lapse video microscopy reveals  that 
motile IMZ cells migrate in random directions on these fu- 
sion  proteins  as  described previously for  intact  bovine 
pFN (Winklbauer and Selchow, 1991). The RGD-contain- 
ing peptide (Peptite) does not support cell migration (Fig. 
9). Interestingly, the GST-9.11a fusion protein, which con- 
tains the mutated synergy site, supports a distinct mode of 
migration from that observed on GST-9.11. The cells re- 
main round (Fig. 3 D), occasionally extend filopodia and 
translocate across the substrate in an apparent "rolling" 
fashion (data not shown). The cells will often stop abruptly 
and sometimes spread briefly. Antibody 1F7, which binds to 
the type III-9 repeat of FN, blocks completely this "migra- 
tion" on GST-9.11a (Fig. 9), however, the cells remain ad- 
herent (Fig. 10 B). These data suggest that region(s) other 
than the PPSRN site in type III-9 are able to contribute to 
this alternate form of IMZ cell migratory activity on FN. 
The HepII region (GST-12.15 and GST-12.15V0) is un- 
able to support the migration of IMZ cells and when both 
the HepII and RGD/synergy regions are present  (GST- 
4.13A0) the cells migrate at approximately the same rate 
as on RGD/synergy region alone (Fig. 9). This indicates 
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Figure 8.  Cell recognition  of the synergy region is positionally 
specified during gastrulation. Diagrams (A) depict location of ex- 
planted regions dissected from stage 8 blastulae and stage 11 gas- 
trulae. Solid bars represent the percentage of cells spread; gray 
bars represent percentage of cells attached. Explanted tissues (A, 
numbered 1-3  and  1-5)  were  dissociated  and  applied  to  (B) 
HpFN,  (C)  GST-9.10, (D)  GST-9.11a, or  (E)  GST-12.15V0- 
coated petri dishes. (B-E) Cells from all regions of stage 8 em- 
bryos attach to each substrate but do not spread. (B and C) On 
both HpFN and GST-9.10, the postinvolution mesoderm cells (3) 
of stage 11 gastrulae are mostly spread while significant numbers 
of cells from the dorsal lip (2), endoderm (4), and ventral lip (5) 
are also spread. Animal cap cells (1) attach but do not spread. (D 
and E) On GST-9.11a and GST-12.15V0 cells from all regions at- 
tach but do not spread. At least 200 cells were counted per sub- 
strate per assay. Each assay was repeated six times (n = 6). Error 
bars indicate standard deviations. 
that the  HeplI region, which  supports  IMZ  attachment 
(Figs. 5 and 6), does not affect the rate of migration. 
Previous studies suggest that mesodermal cell-cell adhe- 
sive interactions are important for directional migration in 
vitro (Winklbauer et al., 1992) and may be required to or- 
ganize cell movements during gastrulation in vivo (Niehrs 
et al.,  1994). Therefore, we also performed adhesion and 
migration  assays  using  explanted head  mesoderm  (data 
not shown) in order to compare results obtained with dis- 
persed IMZ cells. Fragments  of head mesoderm adhere 
very tightly to the RGD/synergy region (GST-9.11) and 
cells spread and migrate away from the center of the ex- 
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Figure 9.  Rates of embryonic cell migration on FN fusion pro- 
teins. Explanted involuted marginal zone (Mesoderm), explanted 
animal cap cells (A. C.), and explanted animal cap cells incubated 
in activin-A (A.C. +Activin) were applied to HpFN, PepTite, or 
various fusion proteins. IMZ cells were also applied to GST-9.11a 
and XpFN that had been pre-incubated with mAb 1F7. The cells 
were filmed for 1 h by time-lapse videomicroscopy. Cell paths 
were traced using the center  of the cell as the origin. The path 
length was measured and used to generate an average rate of mi- 
gration  for each substrate.  Activin-induced and uninduced ani- 
mal cap cells are not included in the 1F7 blocking experiments. 
n/> 10 cells for each value. Error bars indicate standard deviation. 
plants. This behavior is identical to that reported for ex- 
plants on intact FNs (Winklbauer, 1990). Head mesoderm 
explants on the RGD-containing fusion protein containing 
the synergy site mutation (GST-9.11a) adhere weakly and 
do not move as  a  cohesive mass or as  single  cells  away 
from the  explant.  The  same  is  true  of head  mesoderm 
plated onto HeplI fusion protein (GST-12.15V0). Hence, 
the migration of these cells in groups correlates with their 
ability to recognize the synergy site. 
Injection of an Antibody that Blocks Migration 
Blocks Gastrulation 
A  monoclonal antibody  (mAb  1F7)  was  obtained  that 
blocks spreading (Fig. 10 B) and migration (Fig. 9) of IMZ 
cells  on intact FNs and FN fusion proteins containing the 
RGD/synergy sites, mAb 1F7 does not, however, interfere 
with cell attachment to RGD and HepII-containing fusion 
proteins or to Xenopus pFN (Fig.  10 B). The epitope rec- 
ognized by this antibody is located in the type III-9 repeat 
of FN as determined by Western blot analysis of fusion 
proteins corresponding to the central cell-binding domain 
(data not shown). This mAb was used to investigate the 
importance  of  synergy-region-dependent cell  migration 
during gastrulation. The mAb 4H2 was used as a control in 
these experiments because it also recognizes an epitope in 
type III-9 but has no affect on IMZ attachment, spreading, 
or migration (Fig. 10 A). Purified mAbs were injected at a 
concentration of 10 mg/ml (60 nl) into the blastocoels of 
stage 9-9.5  embryos. Injected embryos were  analyzed at 
various  time  points  from  gastrulation  through  tailbud 
stages  (Fig.  11).  Mesoderm involution proceeds in mAb 
1F7-injected  embryos, but  blastopore  closure  is  delayed 
relative to control (mAb 4H2)-injected embryos (Fig.  11, 
A  and D). Table II summarizes data obtained from three 
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Figure 10.  Monoclonal antibody  1F7 blocks spreading  of IMZ 
cells. Adhesion assays were done using fusion protein coated sub- 
strata previously incubated in either mAb 4H2 or mAb 1F7. The 
percentage of cells attached (gray bars) and spread (black bars) 
was determined as described in the Materials and Methods. (A) 
Preincubation with control mAb 4H2 has no affect on cell attach- 
ment and spreading on XpFN, GST-9.11, or GST-12.15V0 (com- 
pare to Fig. 4 A). (B) Preincubation of substrates with mAb 1F7 
prevents cells from spreading on the RGD/synergy-site contain- 
ing proteins (XpFN and GST-9.11) but has no affect on attach- 
ment  to the  HeplI-containing  fusion protein  GST-12.15V0. At 
least 100 ceils were counted per assay. Each assay was repeated 
eight times (n = 8). Error bars indicate standard deviations. 
representative  experiments.  The  gastrulation  defect  ob- 
served with mAb 1F7 is similar to that of embryos injected 
with  an  antibody that blocks adhesion to the  RGD site 
(Ramos et al., 1996). 
The early mesodermal marker brachyury (Xbra; Smith 
et al., 1991) was used to confirm the location of the meso- 
derm in 1F7-injected embryos by whole mount in situ hy- 
bridization. Xbra mRNA expression is confined to a broad 
circumblastoporal ring of mesoderm in  1F7-injected em- 
bryos at stage 12 (Fig.  12, C and D). In contrast, Xbra ex- 
pression in 4H2-injected embryos reveals the presence of a 
notochord, indicating normal axial patterning (Fig.  12, A 
and B). The differences in phenotype between 1F7-injected 
embryos and 4H2-injected control embryos become more 
striking as development proceeds (Fig.  11, E and F). Most 
of the 1F7-injected embryos fail to neurulate properly and 
lack  anterior neural folds. These  embryos are  truncated 
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when  injected  into the blastocoel.  Repre- 
sentative  4H2-  and  1F7-injected  embryos 
are shown at stages corresponding  to late 
gastrula  (stage  12; A and D), late neurula 
(stage 21; B and E), and tailbud (stage 35; C 
and F). Blastopore closure is delayed in (D) 
mAblF7-injected embryos compared to (A) 
control  mAb  4H2-injected  embryos.  (E) 
Approximately  75%  of mAb  1F7-injected 
embryos do not neurulate normally and (F) 
form severely truncated tailbud  stage  em- 
bryos lacking head and tail structures (com- 
pare to C). 
along the  anterior-posterior axis  and  lack head  and  tail 
structures (Fig. 11 F). These data confirm that type 111-9- 
mediated migration on FN is required for normal gastrula- 
tion movements and mesoderm patterning in Xenopus. 
Discussion 
We present evidence that the FN-dependent adhesive and 
migratory behaviors of cells that comprise the early Xeno- 
pus embryo are regionally regulated during the process of 
gastrulation.  Only IMZ cells spread  and migrate on the 
RGD/synergy region of FN while other cells of the gas- 
Table II. Antibody Injection Experiments 
Number  Number  Number  Number 
Experiment  Antibody  injected  normal  abnormal  dead 
1  4H2  53  50  0  3 
1F7  64  2  60  2 
2  4H2  71  66  0  5 
1F7  115  30  79  4 
3  4H2  50  50  0  0 
1F7  50  10  39  1 
Stage 9-9.5 embryos were injected with 600 ng of purified antibody as described in 
Materials and Methods. Number of abnormal refers to embryos arrested as late gastm- 
lae. Data from three representative experiments are shown. 
trula do not. Animal cap ectoderm artificially induced to 
become mesoderm by activin-A display adhesive behav- 
iors similar to endogenously induced IMZ.  In each case, 
spreading is dependent on synergy region recognition and 
does not involve HeplI. We show that although these cells 
are less adherent to FN fusion proteins containing a muta- 
tion in the synergy site, they are still able to migrate as sin- 
gle cells.  This motility is distinct from normal RGD/syn- 
ergy-containing proteins,  however,  and  head  mesoderm 
explants do not spread or migrate when applied as intact 
tissue. Finally, we present evidence that IMZ cell interac- 
tion with the synergy region of FN is required for normal 
gastrulation movements in vivo. 
The most significant regionally specified change in em- 
bryonic cell adhesion that we report in this  study is the 
ability of IMZ to recognize the synergy region of FN as 
gastrulation movements commence. Previous reports noted 
that all the cells of the early gastrula are able to attach to 
FN via the RGD site in vitro, but the adhesive characteris- 
tics of regional cell populations differ (Winklbauer, 1988, 
1990; Smith et al., 1990). We now show that differences in 
the major types of adhesive behaviors observed (e.g., at- 
tached vs spread and migratory) arise from recognition of 
the synergy site in response to mesoderm inducing signals. 
The molecular mechanism by which activin induces animal 
cap cells to switch rapidly from nonmotile attachment via 
RGD binding to motile attachment and spreading via the 
RGD/synergy region is not understood. We report else- 
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situ  hybridization  analyses 
reveal  the  localized  expres- 
sion of Xbra mRNA in the 
mesoderm of (A and B) mAb 
4H2  and  (C  and  D)  mAb 
1F7-injected  gastrulae.  (B) 
Higher magnification view of 
single mAb 4H2-injected em- 
bryo  reveals  presence  of  a 
normal  notochord  (arrow). 
(D) Higher magnification  view 
of single  mAb  1F7-injected 
embryo shows extensive  in- 
volution  of  mesoderm  but 
lacks evidence of an organized 
notochord. 
where, however, that this switch in adhesive activity is in- 
dependent of new integrin receptor expression at the cell 
surface  after  exposure  to  activin  (Ramos  et  al.,  1996). 
These data suggest that an integrin already present on the 
embryonic cell surface is "activated" following activin-in- 
duction in such a way as to alter receptor affinity and pro- 
mote recognition of the synergy site. Similar inside-out sig- 
naling  mechanisms  have been proposed for integrins in 
other systems (for reviews see Hynes, 1992; Williams et al., 
1994).  For example, et5131 is activated in T cells after anti- 
gen binding. This activation leads to increased adhesion of 
the cells to FN without changing the surface level expres- 
sion of a5131 (Shimuzi et al., 1990; Chan et al.,  1991).  Our 
results could, therefore, be explained by a  change in the 
activation state of et5131 on induced animal cap cells in vitro 
and on presumptive mesoderm cells in vivo. The ot5131  re- 
ceptor is a likely candidate for mediating changes in RGD/ 
synergy site-dependent adhesive response in Xenopus em- 
bryos, in part because it is expressed at the surface of all cells 
from cleavage stages through gastrulation (Joos et al., 1995). 
A putative integrin-binding site in the synergy region of 
human FN (PHSRN) has been identified and shown to be 
recognized by the O~llb~  3  (Bowditch et al.,  1994)  and tx5131 
(Aota et al., 1994)  receptors. The arginine residue in this 
sequence is important for adhesive function (Aota et al., 
1994) and is conserved in FNs from all species including 
Xenopus (PPSRN; DeSimone et al.,  1992). We show that 
spreading  of Xenopus  IMZ  and  activin-induced  animal 
cap cells is inhibited when the cells are cultured on fusion 
proteins in which this arginine has been mutated to an ala- 
nine. This suggests that cell recognition of this region in re- 
sponse to inductive signals leads to a conformational change 
that alters the ligand-binding "pocket" of et5131 so that it 
can accomodate the synergy site. Recent studies by Danen 
et al. (1995) demonstrate that activated forms of (15131 can 
bind the RGD site of FN with increased affinity indepen- 
dent of PHSRN whereas "low affinity" forms of the recep- 
tor are able to recognize the synergy site. One possibility is 
that local inductive interactions maintain etsI31 in a low af- 
finity state  on the IMZ,  thereby enabling these  cells to 
bind the synergy region and spread and migrate on FN. 
This hypothesis predicts that in the absence of mesoderm 
inducing signals the receptor could exist in a default high 
affinity state in other regions of the embryo, for example, 
on the surfaces of blastocoel roof ectodermal cells, which 
assemble the FN matrix in vivo. Interestingly, it has been 
reported recently that FN matrix assembly is  dependent 
on integrin activation state with only high affinity forms of 
the receptor capable of supporting fibrillogenesis (Wu et 
al.,  1995).  Thus,  early embryonic inductive  interactions 
may play a role in specifying the spatial and temporal reg- 
ulation of diverse integrin-dependent adhesive functions. 
Recognition of the  PPSRN  site  has  important  conse- 
quences for the spreading and migration of IMZ cells. We 
confirm that the presence of this site is required for IMZ 
cell spreading as described for other cell types (Aota et al., 
1994; Bowditch et al., 1994).  Of particular interest in the 
present study, however, is the demonstration that recogni- 
tion of PPSRN can be regulated by inside-out signals. Al- 
though cell spreading is inhibited on PPSAN mutated fu- 
sion  proteins  such  as  GST 9.11a,  significant motility of 
dispersed cells can still be observed (Fig. 9). The 1F7 mAb 
completely abolishes this migration, suggesting that addi- 
tional sequences within type 111-9 are likely to be contrib- 
uting  to  synergy region  adhesive  activity.  Interestingly, 
GST 9.11a, unlike GST 9.11  or intact pFN, does not sup- 
port the motility of intact explants. This also suggests that 
cell-cell interactions may influence adhesion to the syn- 
ergy region of FN. This latter point is important in view of 
the  fact that most of the  IMZ translocates directionally 
across the blastocoel roof as a cohesive population (Keller 
and Winklbauer, 1992). 
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the HepII region of FN and that this interaction requires 
the presence of the PPRRAR sequence located in the type 
III-13 repeat, as described previously for other cell types 
(Barkalow and Schwarzbauer, 1991;  Busby et al.,  1995). 
We confirm that embryonic cell attachment to HepII is in- 
tegrin independent and unlike adhesion to RGD/synergy, 
is not positionally regulated in the early embryo. Winkl- 
bauer (1990) reports that adhesion to pFN substrates is in- 
hibited in the presence of RGD peptides suggesting that 
RGD-independent adhesion does not play a role in meso- 
derm attachment to FN. Although we cannot account con- 
clusively for these differences in results, our earlier obser- 
vations that IMZ cells will attach to FN in the presence of 
RGD peptide (Smith et al.,  1990)  are consistent with the 
present demonstration that the HepII site is responsible 
for this additional adhesive activity. In any event, the pres- 
ence or absence of the HepII region has no obvious effect 
on  RGD/synergy  site-dependent  cell  migration  in  our 
studies whether present in cis or trans (Fig. 4), however, 
HepII is able to substitute partially for RGD in supporting 
cell spreading when present in  cis with the  synergy site 
(Fig. 4 C; GST-6.15e). Although we cannot rule out a role 
for HepII in gastrulation, mAb perturbation experiments 
(Fig. 11 and Ramos et al., 1996) indicate that HepII is not 
sufficient to "compensate" for a loss of IMZ cell adhesion 
to the  RGD  site and/or synergy region.  Several reports 
suggest that cell surface-associated heparan sulfate pro- 
teoglycans (HSPGs) are important in the binding of the 
growth factors FGF and activin (Brickman and Gerhardt, 
1994; Sokol, 1994).  Removal of HSPGs from the cell sur- 
face inhibits induction of mesoderm by these factors and 
thus perturbs gastrulation. It is possible, therefore, that the 
attachment of IMZ and  activin-induced cap cells to the 
HepII region in vitro does not represent an adhesive func- 
tion for this region in vivo. 
The hypothesis that FN plays a role in supporting meso- 
dermal cell movements during amphibian gastrulation was 
addressed in several previous studies. Polyclonal antibod- 
ies directed against FN are reported to perturb gastrula- 
tion in Pleurodeles (Boucaut et al.,  1984a) and Xenopus 
(Howard et al.,  1992)  embryos after microinjection into 
the blastocoel. RGD peptides inhibit Xenopus mesoderm 
adhesion and migration on FN in vitro (Winklbauer, 1990) 
and a monoclonal antibody that blocks attachment to the 
RGD site in vitro, perturbs gastrulation in vivo (Ramos et 
al.,  1996).  Hence, mesoderm interaction with  the  RGD 
site of FN is required for this process. These studies do not 
address  whether  FN  is  required  simply  as  an  adhesive 
ligand or if active cell migration on this ECM protein is es- 
sential for normal gastrulation to proceed. This distinction 
has important consequences for understanding the mecha- 
nisms  involved in  gastrulation  movements.  It  has  been 
proposed  that  the  primary  force  driving  gastrulation 
movements in Xenopus is the process of convergence and 
extension, in which cells of the IMZ intercalate to form a 
narrower and longer tissue array (Keller and Winklbauer, 
1992). The present studies demonstrate that IMZ recogni- 
tion of the synergy region in type III-9 is required for cell 
spreading and migration on FN in vitro (Fig. 4) and gastru- 
lation in vivo (Fig. 11). The 1F7 mAb, which binds to the 
type III-9 repeat, blocks the spreading and migration of 
IMZ and induced animal cap ceils on intact Xenopus pFN 
(Figs. 9 and  10).  When injected into the blastocoel, this 
mAb causes a disruption in the anterior progression of the 
IMZ (Fig. 12), but has relatively little effect on blastopore 
closure, and,  presumably,  convergence extension move- 
ments. Although qualitatively less severe, the phenotypes 
of 1F7-injected embryos are very similar to those obtained 
after injection of a mAb that blocks adhesion to the RGD 
site in type 111-10 (Ramos et al.,  1996).  Taken together, 
these data suggest that FN-dependent cell migration is re- 
quired for normal mesodermal movements along the blas- 
tocoel roof. In the absence of cell interactions with the 
RGD/synergy region of FN, presumptive mesoderm invo- 
lutes but fails to reach its normal position in the embryo. 
The resulting range of phenotypes observed (e.g., trunca- 
tion along anterior-posterior axis, defects in head and axial 
structures) is consistent with this model. Interestingly, FN 
homozygous null mouse embryos share many of these fea- 
tures (George et al., 1993). 
In conclusion, these studies demonstrate that adhesion 
to the RGD site and synergy region of FN is required for 
gastrulation in Xenopus.  We also show that the initiation 
of cell migration on FN can be regulated by inductive sig- 
nals and that the switch to a motile state involves integrin- 
dependent activation of synergy site recognition. Additional 
efforts will be required to confirm the identities of the in- 
tegrins involved in this process and to elucidate the molec- 
ular mechanisms responsible for regulating positional and 
temporal changes in RGD/synergy site-dependent adhe- 
sive behaviors by inside-out signals. 
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